Sativex® for Relieving Persistent Pain in Participants With Advanced Cancer

NCT01262651 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

397

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain
Advanced Cancer

Interventions

DRUG: Nabiximols
DRUG: Placebo (GA-0034)

Sponsor

GW Pharmaceuticals Ltd

Collaborators

[object Object]